Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

<< Previous
Bullboard Posts
Next >>
Post by sgallant308on Apr 09, 2018 1:51pm
160 Views
Post# 27854078

(NVCN) presented current consensus target price of $1.88 US

(NVCN) presented current consensus target price of $1.88 UShttps://www.analystrecommendation.com/2018/04/02/neovasc-inc-nvcn-trend-is-considered-bearish-as-stock-price-is-80-49-down-from-50-sma/


Neovasc Inc. (NVCN) trend is considered bearish as stock price is -80.49% down from 50 SMA

 

 

Investors are looking attentively on Neovasc Inc. (NVCN) as shares traded with negative change of -49.17% at $0.06 during last trading day on a U.S. exchange. This stock price move and price percentage is noteworthy to traders as it shows final value of stock and how much it changed in recent trading session. 234322749 shares traded on hands in the recent trading session. It’s an average volume stands with 19320.84K shares. Take a review on its volatility measure, 20.76% volatility was seen in a month and for the week it was observed at 19.82%. It is trading at a P/S value of 0.7.

As for a performance, the company’s showed return of -89.83% since start of the year. This YTD return is simply the amount of profit generated by an investment since the beginning of the current calendar year. YTD calculations are commonly used by investors and analysts in the assessment of portfolio performance because of their simplicity. The stock revealed activity of -46.26% for the past five days. The monthly performance reflected change of -74.56% and indicated -90.32% performance in last quarter.

Earnings Expectations: Investors may be looking for the earnings expectations in coming days; how much it could deliver earnings ability. The firm declared EPS of $0.25 for the trailing twelve months period. If we take an observation in front to the next coming days, Street analysts have hope earnings growth of 79.70% for this year and may be getting earnings growth of 50.00% for next year.

Analysts Target Price: Wall Street analysts that cover the Neovasc Inc. (NVCN) presented current consensus target price of $1.88. The price target is the price an analyst believes the stock will achieve during their investment time horizon, which for most firms is 12 months. Investors should not rely solely on an analyst’s recommendation when deciding whether to buy, sell or hold a stock. It is suggested that a little more digging on your part behind what brokerage companies are recommending will always be to your benefit. Currently the analysts who cover the company rated it a consensus rating score of 1.


<< Previous
Bullboard Posts
Next >>